CERK_CAEEL
ID CERK_CAEEL Reviewed; 549 AA.
AC Q9TZI1;
DT 06-MAR-2013, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-2000, sequence version 1.
DT 03-AUG-2022, entry version 133.
DE RecName: Full=Ceramide kinase 1;
DE EC=2.7.1.138;
GN Name=cerk-1 {ECO:0000312|WormBase:T10B11.2};
GN ORFNames=T10B11.2 {ECO:0000312|WormBase:T10B11.2};
OS Caenorhabditis elegans.
OC Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC Rhabditina; Rhabditomorpha; Rhabditoidea; Rhabditidae; Peloderinae;
OC Caenorhabditis.
OX NCBI_TaxID=6239;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=Bristol N2;
RX PubMed=9851916; DOI=10.1126/science.282.5396.2012;
RG The C. elegans sequencing consortium;
RT "Genome sequence of the nematode C. elegans: a platform for investigating
RT biology.";
RL Science 282:2012-2018(1998).
CC -!- FUNCTION: Catalyzes the phosphorylation of ceramide to form ceramide 1-
CC phosphate. {ECO:0000250}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=an N-acylsphing-4-enine + ATP = ADP + an N-acylsphing-4-enine
CC 1-phosphate + H(+); Xref=Rhea:RHEA:17929, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:30616, ChEBI:CHEBI:52639, ChEBI:CHEBI:57674,
CC ChEBI:CHEBI:456216; EC=2.7.1.138;
CC -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FO080731; CCD66240.1; -; Genomic_DNA.
DR PIR; T33517; T33517.
DR RefSeq; NP_491977.1; NM_059576.4.
DR AlphaFoldDB; Q9TZI1; -.
DR SMR; Q9TZI1; -.
DR BioGRID; 37868; 1.
DR DIP; DIP-25504N; -.
DR STRING; 6239.T10B11.2; -.
DR EPD; Q9TZI1; -.
DR PaxDb; Q9TZI1; -.
DR PeptideAtlas; Q9TZI1; -.
DR EnsemblMetazoa; T10B11.2.1; T10B11.2.1; WBGene00020398.
DR GeneID; 172423; -.
DR KEGG; cel:CELE_T10B11.2; -.
DR UCSC; T10B11.2; c. elegans.
DR CTD; 172423; -.
DR WormBase; T10B11.2; CE18241; WBGene00020398; cerk-1.
DR eggNOG; KOG1115; Eukaryota.
DR GeneTree; ENSGT00940000168717; -.
DR HOGENOM; CLU_472760_0_0_1; -.
DR InParanoid; Q9TZI1; -.
DR OMA; CEQWIQV; -.
DR OrthoDB; 681139at2759; -.
DR PhylomeDB; Q9TZI1; -.
DR Reactome; R-CEL-1660662; Glycosphingolipid metabolism.
DR UniPathway; UPA00222; -.
DR PRO; PR:Q9TZI1; -.
DR Proteomes; UP000001940; Chromosome I.
DR Bgee; WBGene00020398; Expressed in germ line (C elegans) and 4 other tissues.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0001729; F:ceramide kinase activity; IBA:GO_Central.
DR GO; GO:0102773; F:dihydroceramide kinase activity; IEA:UniProtKB-EC.
DR GO; GO:0001727; F:lipid kinase activity; IBA:GO_Central.
DR GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR GO; GO:0006672; P:ceramide metabolic process; IBA:GO_Central.
DR GO; GO:0016310; P:phosphorylation; IBA:GO_Central.
DR GO; GO:0006665; P:sphingolipid metabolic process; IBA:GO_Central.
DR Gene3D; 3.40.50.10330; -; 1.
DR InterPro; IPR017438; ATP-NAD_kinase_N.
DR InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR Pfam; PF00781; DAGK_cat; 1.
DR SUPFAM; SSF111331; SSF111331; 1.
DR PROSITE; PS50146; DAGK; 1.
PE 3: Inferred from homology;
KW ATP-binding; Kinase; Lipid metabolism; Nucleotide-binding;
KW Reference proteome; Sphingolipid metabolism; Transferase.
FT CHAIN 1..549
FT /note="Ceramide kinase 1"
FT /id="PRO_0000421274"
FT DOMAIN 162..316
FT /note="DAGKc"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT ACT_SITE 235
FT /note="Proton donor/acceptor"
FT /evidence="ECO:0000250"
FT BINDING 172..174
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT BINDING 205..209
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT BINDING 233..236
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT BINDING 240
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT BINDING 277..279
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT BINDING 342
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT BINDING 348
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT BINDING 500..502
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
SQ SEQUENCE 549 AA; 62425 MW; DE95737555534EEB CRC64;
MPNSKKSKKG GDQQHVTIVP VEPVKGENVD TVAYSSRSRI SGESGHLIAD VQSPHAKKHR
IIFDRDHNVF EFRLLDGSAK HIIVYRLDEL LSTTCYPFKI KNGVPIIPTK PTTSDKTLYF
NFVYKKDKQK WRLKQIPVIF YTTSERDYWH SLIDTTLRRV KNRPKNIIIF INPFGGNGKA
QKIFKDNVDA FFWLTPGLRY KVVLTERANH ARDYIVEMPP EQWSAIDGLV SVGGDGLFNE
LLSGALLRTQ TDAGRNIDNP SSHLVTPHIR FGIIGAGSAN SIVSTVHETN DHATSAVHIA
IGSECNVDVC TVHQHQKLIR ISANAISYGW LGDVLRDSEE YRCLGPIRYQ WSALRTTIRH
PIYRGMVQFS LSHKENVNPK DQLPPCLEPC PVCMKPQGND KYDYHWHAEF THVICCVIPT
VTPFTPYGLA PFTGIGDGTL DLALVPRISR FHNMQFMRKV AMYGGKQLYE LDPSLNCYRV
TKWSYQPDAD QEDPGVWNLD GEILEQPKDE PLHFKLHPQL ISFFGRDAAM VKPTKRSFIK
KRKSSIVYQ